ABIO Financial Statements (ABIO) |
||||||||||
Артген биотех (ИСКЧ)smart-lab.ru | % | 2022Q2 | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q4 | LTM ? | |||
---|---|---|---|---|---|---|---|---|---|---|
Report date | 29.08.2022 | 29.04.2023 | 30.08.2023 | 30.08.2023 | ||||||
Currency | RUB | RUB | RUB | RUB | RUB | RUB | ||||
Financial report URL | ||||||||||
Revenue, bln rub | ? | 0.520 | 0.616 | 0.620 | 1.24 | |||||
Operating Income, bln rub | 0.065 | 0.046 | 0.105 | 0.151 | ||||||
EBITDA, bln rub | ? | 0.100 | 0.064 | 0.150 | 0.214 | |||||
Net profit, bln rub | ? | 0.025 | 0.020 | 0.032 | 0.052 | |||||
OCF, bln rub | ? | 0.047 | 0.173 | 0.052 | 0.225 | |||||
CAPEX, bln rub | ? | 0.097 | 0.121 | 0.065 | 0.186 | |||||
FCF, bln rub | ? | -0.091 | 0.049 | -0.077 | -0.028 | |||||
Dividend payout, bln rub | 0.085 | 0.111 | 0.111 | |||||||
Dividend, rub/share | ? | 1 | 1.2 | 1.2 | ||||||
Ordinary share dividend yield, % | 0.0% | 1.6% | 0.0% | 0.0% | 1.2% | 1.3% | ||||
Dividend payout ratio, % | 0% | 425% | 0% | 213% | ||||||
OPEX, bln rub | 0.456 | 0.570 | 0.516 | 1.09 | ||||||
Amortization, bln rub | 0.0 | 0.0 | 0.0 | |||||||
Interest expenses, bln rub | 0.035 | 0.020 | 0.054 | 0.074 | ||||||
Assets, bln rub | 1.75 | 2.04 | 2.36 | 2.36 | ||||||
Net Assets, bln rub | ? | 0.276 | 0.341 | 0.381 | 0.381 | |||||
Debt, bln rub | 0.506 | 0.708 | 0.673 | 0.673 | ||||||
Cash, bln rub | 0.060 | 0.202 | 0.362 | 0.362 | ||||||
Net debt, bln rub | 0.45 | 0.51 | 0.00 | 0.31 | 0.00 | 0.31 | ||||
Ordinary share price, rub | 57.8 | 62.1 | 116.3 | 104.0 | 102.0 | 94.2 | ||||
Number of ordinary shares, mln | 85.0 | 92.6 | 92.6 | 92.6 | 92.6 | 92.6 | ||||
Market cap, bln rub | 4.92 | 5.75 | 10.8 | 9.64 | 9.45 | 8.73 | ||||
EV, bln rub | ? | 5.36 | 6.26 | 10.8 | 9.95 | 9.45 | 9.04 | |||
Book value, bln rub | -0.30 | -0.40 | 0.00 | -0.36 | 0.00 | -0.36 | ||||
EPS, rub | ? | 0.29 | 0.22 | 0.00 | 0.35 | 0.00 | 0.56 | |||
FCF/share, rub | -1.07 | 0.53 | 0.00 | -0.83 | 0.00 | -0.30 | ||||
BV/share, rub | -3.54 | -4.26 | 0.00 | -3.92 | 0.00 | -3.92 | ||||
EBITDA margin, % | ? | 19.2% | 10.4% | 24.2% | 17.3% | |||||
Net margin, % | ? | 4.8% | 3.2% | 5.2% | 4.2% | |||||
FCF yield, % | ? | -0.1% | -0.7% | -0.4% | -0.3% | -0.8% | -0.3% | |||
ROE, % | ? | 14.1% | 13.2% | 13.6% | 13.6% | |||||
ROA, % | ? | 2.2% | 2.2% | 2.2% | 2.2% | |||||
P/E | ? | 126.1 | 127.8 | 239.4 | 185.3 | 295.3 | 167.9 | |||
P/FCF | -54.0 | -136.9 | -125.2 | -122.7 | -311.8 | |||||
P/S | ? | 4.30 | 5.06 | 9.48 | 7.80 | 15.2 | 7.06 | |||
P/BV | ? | -16.3 | -14.6 | -26.5 | -24.0 | |||||
EV/EBITDA | ? | 34.6 | 38.1 | 65.7 | 46.5 | 63.0 | 42.2 | |||
Debt/EBITDA | 2.88 | 3.09 | 0.00 | 1.45 | 0.00 | 1.45 | ||||
R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0 | ||||||
CAPEX/Revenue, % | 19% | 20% | 10% | 15% | ||||||
Financial statement quality | 4 | |||||||||
Investor Presentations | 3 | |||||||||
Smart-lab presence | 1 | |||||||||
Annual report | 3 | |||||||||
Investor site URL | 4 | |||||||||
Investor calendar | 4 | |||||||||
ABIO shareholders |